Effect of Pioglitazone on Nonalcoholic Fatty Liver Disease in Morbid Obese Patients; a Randomized Controlled Trial

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a common obesity-related disease. In this study, we aimed to investigate the effects of pioglitazone on NAFLD in morbid obese patients. MATERIALS AND METHODS: This is a randomized controlled trial study that was performed in 2020–2021 on 44 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayadishahraki, Masoud, Mirfendereski, Sam, Kachuei, Ali, Rafiee Zadeh, Aryan, Mirghaderi, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086638/
https://www.ncbi.nlm.nih.gov/pubmed/37057246
http://dx.doi.org/10.4103/abr.abr_354_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086638/
https://www.ncbi.nlm.nih.gov/pubmed/37057246
http://dx.doi.org/10.4103/abr.abr_354_21

Ejemplares similares